Abstract

Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding

Author(s): Chan Debora Schotik

Issue: Mar/Apr 2001 - Compounding for Animals

Page(s): 97-100

Download in electronic PDF format for $75
  • Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Page 1
  • Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Page 2
  • Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Page 3
  • Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Page 4

Abstract

Regulations for the use of bulk drugs in animals are unclear. In this article, the author focuses on US food and drug regulations, use of bulk drugs to compound for humans and animals, US Food and Drug Administration regulations governing the use of bulk drugs, and regulatory actions. Tables provide a list of proposed bulk drugs suitable for use in compounding for humans, drug products not to be used in compounding and drugs prohibited for extralabel use in food-producing animals.

Related Keywords

  • food and drug regulations
  • medications for animals

Related Categories

  • LEGAL
  • VETERINARY
  • FDA

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Jul/Aug 2015
Pg. 303-305
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Author(s): Miller David G
Mar/Apr 2001
Pg. 97-100
Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding
Author(s): Chan Debora Schotik
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Jan/Feb 2017
Pg. 19-21
When to Compound Medications for Veterinary Patients
Author(s): Forsythe Lauren Eichstadt
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Nov/Dec 2016
Pg. 457-458
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)
Author(s):
Sep/Oct 2021
Pg. 358-362
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Author(s): Cabaleiro Joe
Nov/Dec 2015
Pg. 487-488
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Author(s): Allen Loyd V Jr
May/Jun 2005
Pg. 201-205
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Author(s): Harrington Catherine A, Cauffield Jacintha
Nov/Dec 2002
Pg. 434-437
Regulatory and Operational Issues of Founding a Compounding Pharmacy
Author(s): Smith Lisa K
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
Jan/Feb 2023
Pg. 22-23
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Author(s): Brunner Scott
Nov/Dec 2006
Pg. 446-448
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Author(s): Allen Loyd V Jr
Nov/Dec 2012
Pg. 456-460
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Author(s): Lyon Joanna
Sep/Oct 2014
Pg. 379-380
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Author(s): Blankenship Cynthia E
Sep/Oct 2015
Pg. 389-390
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2005
Pg. 44-46
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List")
Author(s): Allen Loyd V Jr, Ashworth Lisa D
Nov/Dec 2023
Pg. 474-481
Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Author(s): Allen Loyd V Jr